{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:50:57Z","timestamp":1789678257326,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clnu.2023.10.007","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T21:46:48Z","timestamp":1697147208000},"page":"2372-2380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial"],"prefix":"10.1016","volume":"42","author":[{"given":"Nancy Samir","family":"Elbarbary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Abdel Rahman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Abdelaal","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2023.10.007_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fendo.2021.669954","article-title":"Evidence of early diabetic nephropathy in pediatric type 1 diabetes","volume":"12","author":"Mamilly","year":"2021","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.clnu.2023.10.007_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154683","article-title":"Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clnu.2023.10.007_bib3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/MNH.0000000000000275","article-title":"Biomarkers for predicting outcomes in chronic kidney disease","volume":"25","author":"Tummalapalli","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"10.1016\/j.clnu.2023.10.007_bib4","first-page":"7856","article-title":"Increased expression of kidney injury molecule-1 and matrix metalloproteinase-3 in severe Plasmodium falciparum malaria with acute kidney injury","volume":"10","author":"Punsawad","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"10.1016\/j.clnu.2023.10.007_bib5","first-page":"376","article-title":"Protective effects of curcumin on diabetic nephropathy via attenuation of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) expression and alleviation of oxidative stress in rats with type 1 diabetes","volume":"22","author":"Ghasemi","year":"2019","journal-title":"Iranian J Basic Med Sci"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib6","first-page":"1219","article-title":"Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology","volume":"11","author":"Song","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.clnu.2023.10.007_bib7","doi-asserted-by":"crossref","first-page":"F517","DOI":"10.1152\/ajprenal.00291.2005","article-title":"Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury","volume":"290","author":"Vaidya","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clnu.2023.10.007_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.ajkd.2013.09.013","article-title":"Urine stability studies for novel biomarkers of acute kidney injury","volume":"63","author":"Parikh","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"18","key":"10.1016\/j.clnu.2023.10.007_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM199411033311804","article-title":"A\u00a0controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group","volume":"331","author":"Donadio","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.clnu.2023.10.007_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228315","article-title":"The effects of omega-3 fatty acids on diabetic nephropathy: a meta-analysis of randomized controlled trials","volume":"15","author":"Chewcharat","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.10.007_bib11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.clnu.2023.10.007_bib12","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/pedi.13454","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"23","author":"Libman","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.clnu.2023.10.007_bib13","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/diacare.24.9.1560","article-title":"Does microalbuminuria predict diabetic nephropathy?","volume":"24","author":"Tabaei","year":"2001","journal-title":"Diabetes Care"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.clnu.2023.10.007_bib14","first-page":"S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.clnu.2023.10.007_bib15","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/pedi.13444","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes","volume":"23","author":"Bjornstad","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.clnu.2014.06.005","article-title":"Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: randomized, double-blind, placebo-controlled trial","volume":"34","author":"Samimi","year":"2015","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib17","first-page":"OC13","article-title":"Role of omega-3 fatty acids on lipid profile in diabetic dyslipidaemia: single blind, randomised clinical trial","volume":"11","author":"Chauhan","year":"2017","journal-title":"J\u00a0Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.clnu.2023.10.007_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clnu.2015.11.003","article-title":"Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Soleimani","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.10.007_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2019.09.022","article-title":"Nutrition and immunology in mental health: precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments","volume":"85","author":"Chang","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.clnu.2023.10.007_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/pedi.13429","article-title":"ISPAD clinical practice consensus guidelines 2022: nutritional management in children and adolescents with diabetes","volume":"23","author":"Annan","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"5S","key":"10.1016\/j.clnu.2023.10.007_bib21","first-page":"S1","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.clnu.2023.10.007_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ki.2015.314","article-title":"Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes","volume":"89","author":"Nowak","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnu.2023.10.007_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2014.12.029","article-title":"Intima media thickness measurement in children: a statement from the association for European Paediatric Cardiology (AEPC) working group on cardiovascular prevention endorsed by the association for European Paediatric Cardiology","volume":"238","author":"Dalla Pozza","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2023.10.007_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/13510002.2017.1301624","article-title":"Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in \u03b2-thalassemia major","volume":"22","author":"Adly","year":"2017","journal-title":"Redox Rep"},{"issue":"1","key":"10.1016\/j.clnu.2023.10.007_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"issue":"16","key":"10.1016\/j.clnu.2023.10.007_bib26","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1080\/10408398.2021.1875977","article-title":"Omega-3 supplementation and diabetes: a systematic review and meta-analysis","volume":"62","author":"Delpino","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.clnu.2023.10.007_bib27","first-page":"50","article-title":"Effect of omega-3 fatty acid on the fatty acid content of the erythrocyte membrane and proteinuria in patients with diabetic nephropathy","volume":"15","author":"Lee","year":"2015","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.clnu.2023.10.007_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000012775","article-title":"Sodium transport kinetics, cell membrane lipid composition, neural conduction and metabolic control in type 1 diabetic patients. Changes after a low-dose n-3 fatty acid dietary intervention","volume":"43","author":"Stiefel","year":"1999","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/157016109788340659","article-title":"Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management","volume":"7","author":"Cicero","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/ndt\/gfi208","article-title":"Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy\/Ta mice: involvement of MCP-1 suppression and decreased ERK1\/2 and p38 phosphorylation","volume":"21","author":"Hagiwara","year":"2006","journal-title":"Nephrol Dialysis Transplant"},{"key":"10.1016\/j.clnu.2023.10.007_bib31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12933-018-0740-x","article-title":"Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials","volume":"17","author":"O'Mahoney","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.clnu.2023.10.007_bib32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jphp.12744","article-title":"Omega-3 fatty acids in prevention of diabetic retinopathy","volume":"69","author":"Behl","year":"2017","journal-title":"J\u00a0Pharmacy Pharmacol"},{"issue":"4","key":"10.1016\/j.clnu.2023.10.007_bib33","first-page":"243","article-title":"Pathogenesis of diabetic nephropathy","volume":"2","author":"Cao","year":"2011","journal-title":"J\u00a0Diab Investig"},{"key":"10.1016\/j.clnu.2023.10.007_bib34","doi-asserted-by":"crossref","first-page":"E377","DOI":"10.25011\/cim.v37i6.22242","article-title":"Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy","volume":"1","author":"Tekce","year":"2014","journal-title":"Clin Investig Med"},{"issue":"5","key":"10.1016\/j.clnu.2023.10.007_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/diacare.24.5.805","article-title":"Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients","volume":"24","author":"Mollsten","year":"2001","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.clnu.2023.10.007_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF02537161","article-title":"Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester","volume":"25","author":"Hamazaki","year":"1990","journal-title":"Lipids"},{"key":"10.1016\/j.clnu.2023.10.007_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.1997.tb51848.x","article-title":"Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria","volume":"827","author":"Lungershausen","year":"1997","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.clnu.2023.10.007_bib38","doi-asserted-by":"crossref","first-page":"F895","DOI":"10.1152\/ajprenal.00217.2009","article-title":"Vaziri ND Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney","volume":"297","author":"An","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1016\/j.clnu.2023.10.007_bib39","doi-asserted-by":"crossref","first-page":"F306","DOI":"10.1152\/ajprenal.90326.2008","article-title":"Omega-3 fatty acid rich diet prevents diabetic renal disease","volume":"296","author":"Garman","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"10.1016\/j.clnu.2023.10.007_bib40","first-page":"70","article-title":"Omega-3 polyunsaturated fatty acids for the treatment of IgA nephropathy","volume":"6","author":"Hirahashi","year":"2017","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.clnu.2023.10.007_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12937-015-0068-2","article-title":"Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus","volume":"14","author":"Arriens","year":"2015","journal-title":"Nutr J"},{"issue":"11","key":"10.1016\/j.clnu.2023.10.007_bib42","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00296-013-2811-3","article-title":"Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus","volume":"33","author":"Bello","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clnu.2023.10.007_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cofs.2014.12.007","article-title":"Evaluating the therapeutic value of omega-3 polyunsaturated fatty acid supplementation on polycystic kidney disease and co-morbidities","volume":"2","author":"Tou","year":"2015","journal-title":"Curr Opin Food Sci"},{"key":"10.1016\/j.clnu.2023.10.007_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nutd.2012.10","article-title":"Dennison RJ Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice","volume":"2","author":"Sapieha","year":"2012","journal-title":"Nutr Diabetes"},{"issue":"12","key":"10.1016\/j.clnu.2023.10.007_bib45","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1161\/CIR.0000000000000709","article-title":"Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association","volume":"140","author":"Skulas-Ray","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clnu.2023.10.007_bib46","article-title":"Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial","volume":"19","author":"O'Mahoney","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2023.10.007_bib47","first-page":"CD003205","article-title":"Omega 3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus","volume":"5","author":"Hartweg","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.clnu.2023.10.007_bib48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1515\/jpem-2018-0409","article-title":"Effect of supplementation with omega-3 fatty acids on hypertriglyceridemia in pediatric patients with obesity","volume":"32","author":"Del-R\u00edo-Navarro","year":"2019","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.clnu.2023.10.007_bib49","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/jama.2017.1926","article-title":"Dietary intake of omega-3 fatty acids from fish and risk of diabetic retinopathy","volume":"317","author":"Chew","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2023.10.007_bib50","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s00125-015-3628-2","article-title":"Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial","volume":"58","author":"McCormick","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.10.007_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.plefa.2007.10.004","article-title":"Regulation of adhesion molecule expression in human endothelial and smooth muscle cells by omega-3 fatty acids and conjugated linoleic acids: involvement of the transcription factor NF-kappaB?","volume":"78","author":"Goua","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clnu.2023.10.007_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jnutbio.2010.01.007","article-title":"Docosahexaenoic acid attenuates VCAM-1 expression and NF-kappaB activation in TNF-alpha-treated human aortic endothelial cells","volume":"22","author":"Wang","year":"2011","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.clnu.2023.10.007_bib53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clnu.2023.10.007_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ajcn\/61.1.121","article-title":"Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus","volume":"61","author":"Puhakainen","year":"1995","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.psychres.2007.06.029","article-title":"Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial","volume":"161","author":"Emsley","year":"2008","journal-title":"Psychiat Res"},{"key":"10.1016\/j.clnu.2023.10.007_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2018.01.001","article-title":"Safety and tolerability of prescription omega-3 fatty acids: a systematic review and meta-analysis of randomized controlled trials","volume":"129","author":"Chang","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.chc.2014.02.002","article-title":"Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviors","volume":"23","author":"Gow","year":"2014","journal-title":"Child Adolescent Psychiatr Clin"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib58","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ajcn\/84.3.540","article-title":"Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation","volume":"84","author":"Mostad","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2023.10.007_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCG.0000000000000099","article-title":"Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis","volume":"49","author":"Dasarathy","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.clnu.2023.10.007_bib60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/biof.1277","article-title":"Effects of N-3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance","volume":"42","author":"Derosa","year":"2016","journal-title":"BioFactors"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423003254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423003254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:13:32Z","timestamp":1759367612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423003254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0261561423003254"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.10.007","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omega-3 fatty acids supplementation improves early-stage diabetic nephropathy and subclinical atherosclerosis in pediatric patients with type 1 diabetes: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}